Shandong Xinhua Pharmaceutical Company Limited announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 4,399.154 million compared to CNY 3,959.689 million a year ago. Operating income was CNY 313.745 million compared to CNY 261.545 million a year ago. Net income was CNY 238.601 million compared to CNY 193.331 million a year ago. Basic earnings per share from continuing operations was CNY 0.38 compared to CNY 0.31 a year ago. Sales was CNY 14.628 million compared to CNY 4.343 million a year ago. Operating loss was CNY 142.906 million compared to CNY 131.479 million a year ago. Net loss was CNY 144.191 million compared to CNY 127.209 million a year ago. Basic loss per share from continuing operations was CNY 0.23 compared to CNY 0.2 a year ago.